Cesca Therapeutics Inc., of Rancho Cordova, Calif., priced an underwritten public offering of approximately 7.5 million units consisting of an aggregate of approximately 7.5 million common shares and warrants to purchase approximately 2.3 million additional shares, at $1.50 per unit.